INTRODUCTION
Osteonecrosis (ON) can accompany a wide variety of disease processes, such as trauma, hemoglobinopathy, exogeneous and endogeneous hypercortisolism, alcoholism, pancreatitis, dysbaric conditions, and Gaucher's disease (1) (2) (3) (4) . Following steroid therapy the increase in pressure and fat cell volume in the marrow cavity leads to a collapse of the sinusoids in the femoral head. This phenomenon may be a contributing factor to some forms of ON (5) (6) (7) (8) .
Aplastic anemia is a rare hematologic disorder characterized by hypocellular fatty marrow (9) . The high fat content of the marrow in aplastic anemia results in high signal intensity (SI) on magnetic resonance (MR) images, reflecting the preponderance of fatty marrow and the relative lack of hematopoietic marrow (10) (11) (12) (13) (14) (15) . Using MR imaging, fat conversion has been observed to occur in the proximal femoral metaphysis of steroid-treated patients and is increased in osteonecrotic hips (8, (16) (17) (18) (19) . Treatment-related ON in patients with aplastic anemia has been reported in several cases (20) (21) (22) (23) , but a causal relationship between aplastic anemia and ON has not yet been determined.
The purpose of this study was to evaluate the incidence and clinical and MR imaging features of ON in the hips of patients with aplastic anemia whose bone marrow had been replaced by extensive fat.
MATERIALS AND METHODS
From January 1994 to May 1998, we performed MR imaging in 241 patients with aplastic anemia to assess bone marrow cellularity at the time of initial diagnosis. They were 125 male and 116 female patients with a mean age of 31 yr (range, 16-60 yr). MR imaging of bone marrow was performed with a 0.5 T (Gyroscan T5, Philips, Eindhoven, The Netherlands) superconductive MR scanner. The imaging protocol for evaluating the cellularity of bone marrow was as follows: sagittal T1-weighted image (T1W1) (TR/TE=560/30 msec) and short tau inversion recovery (STIR), (TR/TE/TI=1,400/30/120 msec) images of the lumbar spine with a 5-mm thickness, a 0.5-mm intersection gap, a 205×256 matrix, four-signal acquisition, and a 350-mm field of view and coronal T1WI of the pelvis (TR/TE=560/30 msec) with a 6-mm slice thickness and a 0.6-mm intersection gap. In a limited number of cases we used a 1.5 T (Magnetom Vision Plus, Siemens, Erlangen, Germany) superconductive MR scanner and added fat-saturated, enhanced, T1-weighted sequences.
On the coronal T1WI of the pelvis obtained during MR imaging of the bone marrow, we diagnosed ON and assessed bilaterality, as well as the extent of ON, and the marrow status of proximal femoral metaphysis, such as fatty or red, by visual inspection with the agreement of two radiologists. ON was diagnosed when the normal intense signal of the marrow fat was noticeably decreased in the subchondral region of the
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Key Words : Anemia, Aplastic; Osteonecrosis; Hip; Bone Marrow; Magnetic Resonance Imaging femoral head, as well as then the border of the necrosis was demarcated by a rim of low signal (24, 25) . The clinical presence or absence of hip pain and history of medication before the development of ON were also evaluated.
RESULTS
Among the 241 aplastic anemia patients whose bone marrow was examined using MR imaging, we found ON of the hip in 19 patients. The cumulative incidence of ON of the hip in patients with aplastic anemia was 7.9%. There were 15 men and 4 women, who ranged in age from 19 to 46 yr (mean 35 yr).
In 14 of these patients, both hips were affected while five patients had unilateral ON. Therefore, a total of 33 hips were involved. In 26 of these hips, the extent of necrosis exceeded 50% of the femoral heads but the remaining seven hips exhibited only small crescentric subchondral defects. Necrotic areas revealed early change of high SI isointense to adjacent fat marrow or only slightly decreased SI. All hips exhibited marked fatty marrow conversion with the exception of the five hips associated with marrow edema in the proximal femoral metaphysis.
Five patients (No. 6, 10, 12, 14, 18) already had ON at the time of MR imaging despite having no history of previous medication (Fig. 1) . Hip pain was reported in ten of the nineteen patients. Twelve patients received antilymphocyte globulin six months to four years before MR imaging (Fig. 2) . In seven patients, corticosteroid (prednisolone, 4 mg/kg daily initially, then tailing off to zero over 3 weeks) was also administered for prevention of serum sickness and androgen was adminis- Fig. 1 . A 42-yr-old woman (patient No.18) with moderate aplastic anemia shows unilateral osteonecrosis on the left femoral head on a coronal T1-weighted MR image (560/30) of the pelvis. Although there was no evidence of osteonecrosis on the right side, the proximal femoral metaphysis showed high signal intensity, indicating that the marrow was predominantly fatty. At the time of this initial MR imaging, this patient already had an osteonecrosis of the hip but had no pain; the patient had no history of prior medication. Table 1 .
DISCUSSION
Aplastic anemia is a potentially severe marrow disorder characterized by peripheral pancytopenia and marrow that is largely devoid of hematopoietic cells; while retaining the basic marrow architecture or stroma, hematopoietic cells are replaced by large amounts of fat (9) . MR imaging has been proposed as a noninvasive and relatively rapid method for evaluation of the bone marrow composition. An aplastic marrow demonstrates focal or diffuse bright SI according to the amount of replaced fatty marrow on T1WI and fatty infiltration in bone marrow can be confirmed by fat suppression images (10) (11) (12) (13) (14) . Meanwhile, as we evaluated the cellularity of bone marrow using MR imaging for initial assessment of severity in patients with aplastic anemia, we found ON of the hip in 19 of the 241 patients with aplastic anemia during the 4 yr and 5 months. There were few data on the incidence or prevalence of ON among corticosteroid-treated patients and other groups at risk (1) . A systemic review of the published literature estimated the incidence of ON of the hip in long-term steroid treatment after transplantation to be approximately 5 to 10% (26, 27) . ON, especially of the femoral head, in association with chronic alcoholism is fairly common. The incidence rate among alcoholics may not be as high as expected with the incidence of 5.3% in medically treated alcoholics (28, 29) . Radiographic and pathologic characteristics of ON in patients with aplastic anemia are not unique, being evident in cases of bony necrosis due to other causes.
In hematopoietic marrow, the vascular structure is characterized by a rich and arborized sinusoidal system. As fatty marrow cell masses increase, the sinusoidal system is replaced by capillaries which are sparse. In the fatty marrow, perfusion of the marrow decreases gradually, and consequent vascularization of this marrow is ineffective due to venous stasis. As a result of this characteristic vascular structure, fatty marrow is more vulnerable to ischemia than hematopoietic marrow (12) . Alternatively, since ischemia or poor perfusion is known to be a factor that induces fatty marrow conversion, such conversion is more accelerated in the marrow cavity where fatty marrow cells begin to be distributed. MR imaging was used to assess marrow composition because it provides information on the amount of fat in bones (8, 10-12, 17, 30-32) . In fact patients with ON have an increased incidence of predominantly fatty marrow in the intertrochanteric portion of the femur depicted by MR image (17) and the ratio of fatty marrow conversion of the proximal femoral metaphysis to that of the greater trochanter measured on T1WI is increased (16) . Therefore MR imaging has enabled researchers to assess the significant increase in the conversions of fatty marrow in the proximal femoral metaphysis and the osteonecrotic hips of patients treated with steroids (8, 16, 17) . In our 28 hips, proximal femoral metaphysis revealed marked fatty marrow conversion irrespective of the age of the patient.
ON has been reported in patients with aplastic anemia treated with antilymphocyte globulin followed by high doses of corticosteroids. In contrast there were no cases of ON with aplastic anemia treated with an antilymphocyte globulin but using a short course of low-dose steroid (20) (21) (22) (23) . In the present study, ON was diagnosed in five patients with aplastic anemia before any medication was administered. Reviewing patients' medical histories, prior to immunotherapy with antilymphocyte globulin had been done six months to four years previously and during that time corticosteroids were only administered in small doses for short periods of time (prednisolone, 4 mg/kg daily, tailing off to zero over three weeks) in order to prevent serum sickness caused by antilymphocyte globulin therapy. We therefore speculate that increased fatty infiltration in the bone marrow of patients with aplastic anemia may be a key factor in the development of ON of the hip. Our study has several limitations. First, we assessed fatty marrow conversion of proximal femoral metaphysis visually and not quantitatively. Secondly, we could not explain why only a unilateral hip was involved with ON in five patients despite the occurrence of bilateral extensive fatty conversion in the proximal femoral metaphysis. Thirdly, longitudinal MR imaging was not undertaken, and only five patients (No. 1, 2, 11, 12, 15) had MR imaging before and after development of ON. Therefore, we must undertake further longitudinal studies to assess the possible roles of antilymphocyte globulin, corticosteroid, or combination therapy in the development of ON in patients with aplastic anemia.
In conclusion, we demonstrated ON of the hip developed frequently in patients with aplastic anemia, its cumulative incidence for 4 yr and 5 months being about 7.4%. Increased fatty marrow conversion of proximal femoral metaphysis may be associated with ON of the hip in patients with aplastic anemia.
